Why the study?
To assess whether patients with AF and a history of ischemic stroke excessively receive reduced doses of NOACs.
Do patients with atrial fibrillation and a history of ischemic stroke excessively receive reduced doses of NOACs without indication?
Do patients with atrial fibrillation and a history of ischemic stroke excessively receive reduced doses of NOACs without indication?
A significant proportion of AF patients with a history of ischemic stroke receive inappropriately reduced doses of NOACs, highlighting a gap in guideline-directed prescribing.
Answers are grounded in this paper and cite their sources.
May indicate inappropriate NOAC underdosing in post-stroke AF; leaves open effects on outcomes and reasons for deviation.
BACKGROUND: The aim of our study was to assess if patients with AF (atrial fibrillation) and a history of ischemic stroke (IS) excessively receive reduced doses of NOACs (non-vitamin K antagonist oral anticoagulants). METHODS: The Polish AF (POL-AF) registry is a prospective, observational, multicenter study, including patients with AF from 10 cardiology hospital centers. In this study we focused on patients with IS in their past. CONCLUSIONS: A significant proportion of AF patients received reduced doses of NOAC after ischemic stroke in a sizeable number of cases, without indication for dose reduction.
No takes yet. Share an insight, caveat, or question.
Szyszkowska et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: